In a study, researchers reviewed the complex relationship between cancer and cardiovascular disease (CVD), focusing on the impact of cancer treatments on heart health. The study presents an extensive overview of the latest research in cardio-oncology and reviews progress in understanding cancer-related CVD, focusing on common gene mutations, risk factors, and metabolic characteristics. It also analyzes the interactions between cancer treatment and CVD drugs.

The study concludes that further research directions should include risk stratification of cancer patients, early detection of myocardial injury, and the application of artificial intelligence for risk prediction and response to cardioprotective interventions.

Reference: Zhao Y, Jia H, Hua X, An T, Song J. Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism. Curr Cardiol Rep. 2023;25(8):863-878. doi: 10.1007/s11886-023-01906-6.